MarketInOut Stock Screener Log In | Sign Up
 

HLB BioStep Co Ltd

KRX • Healthcare • Biotechnology • Quote as of 10/23/2026 15:30
HLB BioStep Co Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeKRX
Market Capitalization91,358 mln
Float14.00 mln

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.66
Likely reliable

Relative Strength

92 / 100
Top performer

Debt / Equity

0.33
Low leverage

Pre-Tax Margin

-23%
Deeply loss-making

ROE

-17.98
Negative

Business Description

Founded in 2012 and based in Incheon, South Korea, HLB bioStep is a contract research organization that supports the development of new drugs and treatments across a wide range of medical areas, including cancer, brain and bone diseases, liver conditions, respiratory illness, and skin disorders. The company provides non-clinical testing, veterinary drug development support, bioanalysis, and clinical trial services to help clients bring their products through the research and regulatory process. Previously operating under the name KNOTUS, the company serves as a broad testing and consulting partner for the life sciences industry in South Korea.

Key Fundamentals

EPS-1,084
ROE-17.98
RPS4,363
ROIC-4.63
ROA-11.80
EBITDA, mln-8,696
EV / EBITDA-6.42
EV / EBIT-3.99
Revenue, mln72,151
EV / Revenue0.77

Quote Details

Last 6,530.00
Change 770 (13.37%)
Open 5,600.00
Volume 1,556,305
Turnover 10,162,671,616
Average Volume 1,847,669

Financial Ratios

Pre-Tax Profit Margin-23
Current Ratio1.28
Price / Book0.58
Price / Tangible Book0.61
Debt / Equity0.33
Price / Sales0.77

Financial Strength

Altman Z-Score1.34
Piotroski F-Score 5 / 9
Beneish M-Score-2.66
Price to Intrinsic Value2.10

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 23.44% 99 / 100   
1 Month 161% 100 / 100   
2 Months 238% 100 / 100   
6 Months 0.93% 87 / 100   
1 Year -3.97% 58 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog